STOCK COMMENTS / EPS CHANGESAnn ANN estimates, price target were raised at UBS. Shares are now seen reaching $40. Estimates were also increased, as higher sales are driving margin expansion, UBS said. Buy rating. HollyFrontier HFC numbers raised at Oppenheimer. Shares are now seen reaching $46. Estimates were also raised on mid-con crude advantage, Oppenheimer said. Outperform rating. Highwoods Properties HIW price target was lowered at Jefferies to $36. Trends somewhat mixed, Jefferies said. Hold rating. Innophos IPHS estimates, price target reduced at Keybanc. IPHS estimates were cut through 2013. Company has a lower outlook for GTSP, Keybanc said. Buy rating and new $63 price target. Mindray Medical MR numbers were raised at Oppenheimer. Shares are now seen reaching $39. Estimates also raised on conservative guidance setting stage for more beats, Oppenheimer said. Outperform rating. Williams Sonoma WSM numbers were increased at UBS. WSM estimates were raised through 2014. Company should see higher sales growth and better operating leverage, UBS said. Neutral rating and new $39 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.
For less than $3 per week, you can get full access to Jim Cramer's intraday market commentary and stock trading strategies - sometimes before he says them on TV! Join now.